Question:medium

Indomethacin when given beyond 36 weeks what will happen?

Show Hint

Recall which molecules maintain patency of the ductus arteriosus and what indomethacin does to their synthesis.
Updated On: Jun 23, 2026
  • Premature closure of PDA
  • Still birth
  • No effect
  • Teratogenic
Show Solution

The Correct Option is A

Solution and Explanation

Pharmacology of Indomethacin: Indomethacin is a non-selective COX inhibitor that blocks prostaglandin synthesis.

$\text{PGE}_2$ and $\text{PGI}_2$ (prostacyclin) maintain patency of the ductus arteriosus (DA) in fetal life through vasodilation. When these prostaglandins are inhibited by indomethacin after 36 weeks, the DA undergoes premature constriction -- i.e., $\textbf{premature closure of PDA}$.

Clinical uses of this mechanism:
- Indomethacin is used therapeutically to close a symptomatic PDA in $\textbf{preterm neonates}$.
- As a tocolytic (stops preterm labour) it is used before 32 weeks; after 36 weeks it risks premature DA closure.

Why not teratogenic? Teratogenicity implies structural birth defects caused during organogenesis (first trimester). Indomethacin's fetal effects are pharmacodynamic (prostaglandin inhibition), not teratogenic.

\[\boxed{\text{Premature closure of PDA}}\]
Was this answer helpful?
0